Cardea is developing a Tech+Bio Infrastructure based on proprietary Biology-gated Transistors, or Cardean Transistors. Cardean Transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with live-streams of multi-omics signal analysis. Until now, life science data was comprised of static snapshot datasets. Cardea uses Cardean Transistors to build chipsets that can be integrated into thousands of “Powered by Cardea” products and applications with features never before seen. Together with their Innovation Partners, Cardea can link biology to computers and measure real-time biological signals - allowing for a new generation of applications Linking up to Life.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $22.9M
Founded date: 2013
Investors 8
Funding Rounds 4
| Date | Series | Amount | Investors |
| 03.05.2022 | - | $1.1M | - |
| 13.01.2021 | Series A | $6.5M | - |
| 17.09.2020 | - | $7.5M | - |
| 22.03.2019 | Series A | $7.8M | - |
Mentions in press and media 13
| Date | Title | Description |
| 02.05.2023 | Paragraf – Acquires Cardea Bio, Extending Graphene Electronics Industry Leadership | Parkwalk is delighted to announce that, in a first for the graphene electronics industry, leading integrated device manufacturer Paragraf is acquiring graphene biosensor market pioneer Cardea Bio to accelerate the mass production of a new g... |
| 02.05.2023 | UK's graphene device manufacturer Paragraf acquires San Diego’s Cardea Bio | Cambridgeshire UK-based graphene device manufacturer Paragraf has acquired San Diego-based Cardea Bio makers of a graphene biosensor. Cardea Bio has been renamed Paragraf USA and Michael Heltzen CEO and co-founder of Cardea Bio becomes EVP ... |
| 03.05.2022 | Cardea Bio Gets $1.1M From Gates Foundation | San Diego-based Cardea Bio, which is developing "electronic nose" technology, says it has received a $1.1M grant from the Bill & Melinda Gates Foundation. According to the company, it will use the funding to develop its electr... |
| 13.01.2021 | Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million | - |
| 12.01.2021 | Cardea Bio has added $6.5M to its Series A raise, bringing the A round total to $20M | - |
| 12.01.2021 | Cardea Bio Takes In $6.5M More In Series A | San Diego-based Cardea Bio, a startup that is developing molecular biology equipment which uses semiconductors to analyze samples, said on Tuesday that it has raised $6.5M more in its Series A funding. The company said the new funding was l... |
| 17.09.2020 | Cardea Bio Raises $7.5M Series A2 | SAN DIEGO, CA, Cardea Bio has announced the first closing in their A2 financing round. >> Click here for more funding data on Cardea Bio >> To export Cardea Bio funding data to PDF and Excel, click here Cardea Bio, who is... |
| 22.03.2019 | Cardea Bio Raises $7.8M Series A-1 Financing | Cardea Bio Inc., a San Diego, CA-based commercial manufacturer of the biology-enabled transistor technology made from graphene-based biosensors, raised $7.8m Series A-1 financing. The round was led by Alexandria Venture Investments, with pa... |
| 22.03.2019 | Cardea Bio Announces $7.8 Million Series A-1 Financing | - |
| 22.03.2019 | Cardea Bio Gets $7.8M For Biosensors | San Diego-based Cardea Bio, a manufacturer of graphene-based, digital biosensors being used to monitor biological systems using semiconductors, announced this morning that it has raised $7.8M in a Series A-1 financing round. The financing w... |
Show more